Annual Cash & Cash Equivalents:
$35.72M-$6.93M(-16.24%)Summary
- As of today, NUVB annual cash & cash equivalents is $35.72 million, with the most recent change of -$6.93 million (-16.24%) on December 31, 2024.
- During the last 3 years, NUVB annual cash & cash equivalents has fallen by -$96.70 million (-73.02%).
- NUVB annual cash & cash equivalents is now -73.02% below its all-time high of $132.42 million, reached on December 31, 2021.
Performance
NUVB Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$607.72M+$146.05M(+31.63%)Summary
- As of today, NUVB quarterly cash & cash equivalents is $607.72 million, with the most recent change of +$146.05 million (+31.63%) on June 30, 2025.
- Over the past year, NUVB quarterly cash & cash equivalents has increased by +$30.55 million (+5.29%).
- NUVB quarterly cash & cash equivalents is now -26.31% below its all-time high of $824.71 million, reached on March 31, 2021.
Performance
NUVB Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NUVB Cash and Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1Y1 Year | -16.2% | +5.3% |
3Y3 Years | -73.0% | -13.7% |
5Y5 Years | +20.1% | +10000.0% |
NUVB Cash and Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
---|---|---|---|---|---|
3Y | 3-Year | -73.0% | at low | -9.8% | +31.6% |
5Y | 5-Year | -73.0% | +20.1% | -26.3% | >+9999.0% |
All-Time | All-Time | -73.0% | +20.1% | -26.3% | >+9999.0% |
NUVB Cash and Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $607.72M(+31.6%) |
Mar 2025 | - | $461.68M(-8.2%) |
Dec 2024 | $35.72M(-16.2%) | $502.69M(-8.5%) |
Sep 2024 | - | $549.13M(-4.9%) |
Jun 2024 | - | $577.17M(-3.3%) |
Mar 2024 | - | $596.98M(-2.3%) |
Dec 2023 | $42.65M(-57.8%) | $611.21M(-1.3%) |
Sep 2023 | - | $619.34M(-1.8%) |
Jun 2023 | - | $630.90M(-2.4%) |
Mar 2023 | - | $646.61M(-2.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $101.10M(-23.7%) | $661.01M(-1.9%) |
Sep 2022 | - | $673.95M(-4.2%) |
Jun 2022 | - | $703.80M(-4.6%) |
Mar 2022 | - | $737.70M(-3.6%) |
Dec 2021 | $132.42M(+345.0%) | $765.39M(-3.3%) |
Sep 2021 | - | $791.78M(-1.8%) |
Jun 2021 | - | $806.61M(-2.2%) |
Mar 2021 | - | $824.71M(+282.3%) |
Dec 2020 | $29.75M | $215.75M(>+9900.0%) |
Sep 2020 | - | $1.34M(>+9900.0%) |
Jun 2020 | - | $3400.00 |
FAQ
- What is Nuvation Bio Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Nuvation Bio Inc.?
- What is Nuvation Bio Inc. annual cash & cash equivalents year-on-year change?
- What is Nuvation Bio Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Nuvation Bio Inc.?
- What is Nuvation Bio Inc. quarterly cash & cash equivalents year-on-year change?
What is Nuvation Bio Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of NUVB is $35.72M
What is the all-time high annual cash & cash equivalents for Nuvation Bio Inc.?
Nuvation Bio Inc. all-time high annual cash & cash equivalents is $132.42M
What is Nuvation Bio Inc. annual cash & cash equivalents year-on-year change?
Over the past year, NUVB annual cash & cash equivalents has changed by -$6.93M (-16.24%)
What is Nuvation Bio Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of NUVB is $607.72M
What is the all-time high quarterly cash & cash equivalents for Nuvation Bio Inc.?
Nuvation Bio Inc. all-time high quarterly cash & cash equivalents is $824.71M
What is Nuvation Bio Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, NUVB quarterly cash & cash equivalents has changed by +$30.55M (+5.29%)